Howard Capital Management Group’s AbbVie ABBV Stock Holding History

Howard Capital Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$506K	Hold	2,012	–	–	0.03%	89
2026 Q1	$438K	Hold	2,012	–	–	0.03%	92
2025 Q4	$460K	Hold	2,012	–	–	0.03%	91
2025 Q3	$466K	Hold	2,012	–	–	0.03%	92
2025 Q2	$373K	Hold	2,012	–	–	0.03%	96
2025 Q1	$422K	Hold	2,012	–	–	0.03%	85
2024 Q4	$358K	Hold	2,012	–	–	0.02%	98
2024 Q3	$397K	Buy	2,012 +339	+20%	+$63.3K	0.03%	93
2024 Q2	$287K	Hold	1,673	–	–	0.02%	98
2024 Q1	$305K	Sell	1,673 -88	-5%	-$15.2K	0.02%	98
2023 Q4	$273K	Hold	1,761	–	–	0.02%	90
2023 Q3	$262K	Hold	1,761	–	–	0.03%	87
2023 Q2	$237K	Sell	1,761 -91	-5%	-$13.3K	0.02%	91
2023 Q1	$295K	Buy	1,852 +507	+38%	+$77.5K	0.03%	86
2022 Q4	$217K	Buy	+1,345	New	+$206K	0.03%	88
2022 Q3	–	Sell	-1,345	Closed	-$206K	–	92
2022 Q2	$206K	Hold	1,345	–	–	0.02%	91
2022 Q1	$218K	Buy	+1,345	New	+$195K	0.02%	100

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Howard Capital Management Group's ABBV Position: Q2 2026 in Review

Howard Capital Management Group held its AbbVie (ABBV) position steady in Q2 2026 at 2,012 shares worth $506K. The position accounts for 0.03% of the portfolio, ranked #89.

Howard Capital Management Group first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Howard Capital Management Group held 2,012 shares of AbbVie worth $506K as of Q2 2026.
Howard Capital Management Group left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.03% of Howard Capital Management Group's portfolio in Q2 2026, its #89 holding.
Howard Capital Management Group first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Howard Capital Management Group's 13F filing for Q2 2026, filed 16 Jul 2026.